| 标题 |
Abstract 3340: RMC-5127, a first-in-class, orally bioavailable mutant-selective RASG12V(ON) inhibitor is central nervous system (CNS)-penetrant and demonstrates anti-tumor activity in a preclinical intracranial xenograft model |
| 网址 | |
| DOI | |
| 其它 |
期刊:Cancer Research 作者:Zhe Chen; Andre Eriksson; Bianca Lee; Jay Dinglasan; Nilufar Montazer; et al 出版日期:2024-03-22 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)